Structure Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	97.83	129.79	26.09	105.31	16.35
Short-Term Investments	338.62	337.53	64.75	2	21.09
Cash & Cash Equivalents	436.45	467.32	90.84	107.31	37.45
Cash Growth	81.20%	414.44%	-15.34%	186.57%	-
Other Current Assets	12.91	6.29	2.25	1.94	0.97
Total Current Assets	449.36	473.61	93.09	109.25	38.42
Property, Plant & Equipment	7.82	8.36	1.29	1.79	0.28
Other Long-Term Assets	0.05	0.05	3.46	0.11	0.01
Total Long-Term Assets	7.87	8.41	4.76	1.91	0.29
Total Assets	457.23	482.02	97.85	111.16	38.7
Accounts Payable	6.54	4.74	6.01	3.48	1.53
Current Debt	1.6	1.44	0.26	0.35	0.15
Other Current Liabilities	15.45	18.56	6.74	4.83	1.37
Total Current Liabilities	23.59	24.74	13.01	8.66	3.04
Long-Term Debt	3.53	4.01	0	0.27	0.13
Other Long-Term Liabilities	0.3	0.3	0	0	0
Total Long-Term Liabilities	3.82	4.31	0	0.27	0.13
Total Liabilities	27.41	29.05	13.01	8.93	3.17
Total Debt	5.13	5.45	0.26	0.62	0.28
Debt Growth	2950.60%	1997.31%	-58.13%	121.79%	-
Retained Earnings	-232.61	-206.57	-116.95	-64.74	-22.95
Comprehensive Income	-0.09	0.52	-0.11	0	-0
Shareholders' Equity	429.82	452.97	-115.14	-64.74	-22.47
Net Cash / Debt	431.32	461.87	90.58	106.69	37.17
Net Cash / Debt Growth	79.20%	409.90%	-15.10%	187.06%	-
Net Cash Per Share	3.09	4.19	9.45	13.10	5.94
Working Capital	425.77	448.87	80.08	100.59	35.38
Book Value Per Share	9.23	12.33	-36.04	-23.86	-10.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).